Concerns over Beijing’s influence, the COVID-19 pandemic and international health policy renew questions about American sovereignty and accountability at the World Health Organization.
By Lucretia Hughes Klucken
WASHINGTON — Growing concerns about China’s influence over the World Health Organization are renewing debate over President Donald Trump’s decision to withdraw the United States from the United Nations health agency, as critics warn that Beijing could gain greater control over international health policy without American participation.
The controversy centers on allegations that China has exercised disproportionate influence over the WHO, particularly during the early stages of the COVID-19 pandemic, when questions emerged about transparency, delayed reporting and the organization’s willingness to challenge information supplied by Chinese authorities.
Supporters of Trump’s withdrawal argue that the United States should not continue funding an international organization they believe has failed to hold Beijing accountable.
Opponents warn that withdrawing could have the opposite effect, reducing American influence while giving China and other governments greater authority over global health decisions.
The disagreement raises a fundamental question about America’s relationship with international institutions: Should the United States remain involved to influence their decisions, or withdraw when those institutions fail to meet American expectations?
Trump Completed U.S. Withdrawal in January
President Trump signed an executive order on Jan. 20, 2025, directing the United States to leave the World Health Organization.
The administration formally completed the withdrawal Jan. 22, 2026, ending American membership, governance participation and direct financial contributions to the organization.
The decision marked a major shift in American foreign and public health policy.
The United States had been a founding member of the WHO since its establishment in 1948 and had played a central role in international disease surveillance, vaccination programs and emergency health responses.
In announcing the completed withdrawal, Health and Human Services Secretary Robert F. Kennedy Jr. and Secretary of State Marco Rubio accused the organization of mishandling the COVID-19 pandemic, failing to implement meaningful reforms and allowing political considerations to compromise its independence.
The administration said the United States would continue international health cooperation through direct relationships with individual countries, private organizations and other partners rather than through WHO membership.
China’s Influence Raises New Concerns
A commentary published Wednesday by Antonio Graceffo in The Gateway Pundit argued that warnings of growing Chinese influence following America’s departure reinforce the case for withdrawing.
The argument challenges European governments and other WHO members to take greater responsibility for countering Beijing’s influence rather than relying on American taxpayers to finance the institution.
The concern is rooted partly in China’s growing diplomatic influence within international organizations.
China remains a WHO member and participates in its governing bodies, policy discussions and international health initiatives.
However, concerns about a possible Chinese takeover should be distinguished from evidence of actual institutional control. There is no established finding that China has taken control of the WHO.
Critics of withdrawal argue that America’s departure could make it easier for Beijing to shape future policies because the United States no longer holds its former voting and leadership position within the organization.
Supporters of Trump’s decision counter that remaining inside an institution with unresolved governance problems would require Americans to continue financing an organization they no longer trust.
Both positions highlight the same geopolitical concern: China’s influence over international institutions is an issue the United States cannot ignore.
COVID-19 Remains at the Center of the Dispute
Much of the controversy dates to the earliest days of the coronavirus pandemic.
COVID-19 was first identified in Wuhan, China, in late 2019.
As the virus spread internationally, questions emerged about whether Chinese authorities had promptly disclosed critical information concerning the outbreak, including the possibility of sustained human-to-human transmission.
The Trump administration has repeatedly accused the WHO of relying too heavily on information supplied by Beijing and failing to challenge Chinese officials aggressively enough.
In its January 2026 withdrawal announcement, the Department of Health and Human Services said WHO officials praised China’s early pandemic response despite evidence of delayed reporting and suppression of information.
The administration also criticized the organization’s handling of questions surrounding the virus’s origins and China’s refusal to provide certain laboratory records and early patient data.
The WHO disputes the characterization that it failed to warn the world.
In a January statement, the organization said it requested additional information from China after receiving reports of unexplained pneumonia cases Dec. 31, 2019.
It also noted that WHO Director-General Tedros Adhanom Ghebreyesus declared a public health emergency of international concern Jan. 30, 2020, when fewer than 100 confirmed cases had been reported outside China.
Those competing accounts remain central to the disagreement over whether the organization demonstrated sufficient independence during the crisis.
American Taxpayers Carried a Significant Financial Burden
Money is another major issue.
Before withdrawing, the United States was among the WHO’s largest financial contributors.
According to the Department of Health and Human Services, annual American contributions in recent years averaged approximately $111 million in mandatory dues and $570 million in voluntary funding.
Mandatory annual dues
$111M
Voluntary annual funding
$570M
Approximate annual U.S. contributions before withdrawal, according to HHS.
That amounted to roughly $681 million annually in combined assessed and voluntary contributions.
The administration argued that Americans were paying a disproportionate share of the organization’s operating costs while receiving insufficient accountability.
Trump’s January 2025 executive order specifically criticized the difference between American and Chinese financial contributions.
For supporters of withdrawal, the issue extends beyond the amount of money involved.
They argue that American taxpayers should not be expected to finance international institutions without meaningful oversight and accountability.
Critics respond that financial contributions gave Washington considerable diplomatic influence and access to global disease surveillance networks.
The question is whether those benefits justified the cost and the administration’s concerns about institutional independence.
Can America Protect Public Health Without the WHO?
The administration maintains that withdrawing from the WHO does not mean withdrawing from international public health cooperation.
Federal officials have outlined plans to work directly with other countries on infectious disease monitoring, emergency preparedness, biosecurity and medical research.
The strategy would allow Washington to negotiate partnerships without participating in the WHO’s broader governance structure.
However, public health specialists have warned that the United States could lose access to important scientific coordination and information-sharing mechanisms.
The WHO facilitates international collaboration involving influenza surveillance, emerging infectious diseases, vaccine development and public health emergencies.
The organization has also played significant roles in campaigns against smallpox, polio, malaria and other diseases.
In its response to the American withdrawal, the WHO warned that the decision could weaken international health security.
The administration argues that the United States can continue protecting Americans while establishing more accountable partnerships outside the organization.
A Broader Fight Over American Sovereignty
The WHO withdrawal is part of a larger effort by the Trump administration to reassess American participation in international organizations.
In January, the White House announced plans to withdraw from 66 additional international bodies and entities that it determined no longer served American interests.
The administration said the decisions were intended to protect national sovereignty, reduce unnecessary spending and redirect federal resources toward American priorities.
The WHO controversy illustrates the broader disagreement over how the United States should exercise influence internationally.
One approach emphasizes maintaining a seat at the table, even when institutions require reform.
The other prioritizes withholding American participation and financial support when an organization fails to meet Washington’s standards.
Both approaches carry consequences.
Leaving an organization can reduce its funding and signal strong opposition to its leadership.
But withdrawing also means surrendering some of the formal influence that comes with membership.
The challenge for the administration is demonstrating that its alternative partnerships can protect Americans while limiting the influence of governments whose interests conflict with those of the United States.
The Question of Accountability
The debate over China’s role in the WHO is unlikely to disappear.
The pandemic exposed serious disagreements about transparency, international cooperation and the responsibility of governments to disclose emerging health threats.
Those questions remain relevant today.
Americans have a legitimate interest in knowing how international organizations use taxpayer money, whether their leadership operates independently and whether their recommendations are supported by reliable scientific evidence.
They also have an interest in ensuring the United States can identify and respond to emerging diseases before those threats reach American communities.
The WHO’s supporters believe continued American participation would provide the strongest opportunity to demand reform and counter Chinese influence.
The Trump administration believes the United States can accomplish those goals more effectively through independent cooperation and direct international partnerships.
The growing debate over Beijing’s influence will test both arguments.
The central question is no longer simply whether America should belong to the World Health Organization. It is whether international health cooperation can remain transparent, accountable and independent of political pressure — with or without the United States at the table.
Original article
Comments